SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:56S1 - FR0013154002 - Common Stock
204.7 EUR
-1.5 (-0.73%)
56S1 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 22 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of 56S1 get a neutral evaluation. Nothing too spectacular is happening here. 56S1 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- 56S1 had positive earnings in the past year.
- In the past year 56S1 had a positive cash flow from operations.
- 56S1 had positive earnings in each of the past 5 years.
- In the past 5 years 56S1 always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.36%, 56S1 is doing worse than 63.64% of the companies in the same industry.
- 56S1 has a Return On Equity of 6.55%. This is comparable to the rest of the industry: 56S1 outperforms 40.91% of its industry peers.
- With a Return On Invested Capital value of 5.94%, 56S1 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for 56S1 is in line with the industry average of 9.34%.
- The last Return On Invested Capital (5.94%) for 56S1 is well below the 3 year average (10.41%), which needs to be investigated, but indicates that 56S1 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.36% | ||
| ROE | 6.55% | ||
| ROIC | 5.94% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
- 56S1 has a Profit Margin (8.98%) which is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of 56S1 has declined.
- 56S1 has a better Operating Margin (16.63%) than 63.64% of its industry peers.
- In the last couple of years the Operating Margin of 56S1 has declined.
- The Gross Margin of 56S1 (45.64%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of 56S1 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.63% | ||
| PM (TTM) | 8.98% | ||
| GM | 45.64% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 56S1 is creating some value.
- The number of shares outstanding for 56S1 has been increased compared to 1 year ago.
- 56S1 has more shares outstanding than it did 5 years ago.
- 56S1 has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.41 indicates that 56S1 is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 4.41, 56S1 is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
- 56S1 has a debt to FCF ratio of 6.84. This is a slightly negative value and a sign of low solvency as 56S1 would need 6.84 years to pay back of all of its debts.
- The Debt to FCF ratio of 56S1 (6.84) is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.50 indicates that 56S1 is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.50, 56S1 perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 6.84 | ||
| Altman-Z | 4.41 |
ROIC/WACC0.61
WACC9.72%
2.3 Liquidity
- A Current Ratio of 1.05 indicates that 56S1 should not have too much problems paying its short term obligations.
- 56S1 has a worse Current ratio (1.05) than 72.73% of its industry peers.
- 56S1 has a Quick Ratio of 1.05. This is a bad value and indicates that 56S1 is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.50, 56S1 is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.5 |
3. Growth
3.1 Past
- 56S1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.11%, which is quite impressive.
- Measured over the past 5 years, 56S1 shows a small growth in Earnings Per Share. The EPS has been growing by 4.19% on average per year.
- Looking at the last year, 56S1 shows a small growth in Revenue. The Revenue has grown by 7.72% in the last year.
- 56S1 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%
3.2 Future
- The Earnings Per Share is expected to grow by 21.17% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 9.86% on average over the next years. This is quite good.
EPS Next Y29.12%
EPS Next 2Y23.48%
EPS Next 3Y22.85%
EPS Next 5Y21.17%
Revenue Next Year7.45%
Revenue Next 2Y8.04%
Revenue Next 3Y9.07%
Revenue Next 5Y9.86%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 47.49 indicates a quite expensive valuation of 56S1.
- Based on the Price/Earnings ratio, 56S1 is valued a bit more expensive than 77.27% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.82, 56S1 is valued quite expensively.
- The Price/Forward Earnings ratio is 38.36, which means the current valuation is very expensive for 56S1.
- Based on the Price/Forward Earnings ratio, 56S1 is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.95, 56S1 is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.49 | ||
| Fwd PE | 38.36 |
4.2 Price Multiples
- 56S1's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 56S1 is more expensive than 77.27% of the companies in the same industry.
- 56S1's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.19 | ||
| EV/EBITDA | 27.46 |
4.3 Compensation for Growth
- 56S1's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as 56S1's earnings are expected to grow with 22.85% in the coming years.
PEG (NY)1.63
PEG (5Y)11.32
EPS Next 2Y23.48%
EPS Next 3Y22.85%
5. Dividend
5.1 Amount
- 56S1 has a yearly dividend return of 0.33%, which is pretty low.
- 56S1's Dividend Yield is comparable with the industry average which is at 0.48.
- Compared to an average S&P500 Dividend Yield of 1.82, 56S1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
5.2 History
- The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
- 56S1 pays out 25.37% of its income as dividend. This is a sustainable payout ratio.
- 56S1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.37%
EPS Next 2Y23.48%
EPS Next 3Y22.85%
SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS STEDIM BIOTECH (56S1.DE) stock?
ChartMill assigns a fundamental rating of 4 / 10 to 56S1.DE.
Can you provide the valuation status for SARTORIUS STEDIM BIOTECH?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (56S1.DE). This can be considered as Overvalued.
How profitable is SARTORIUS STEDIM BIOTECH (56S1.DE) stock?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for 56S1 stock?
The Price/Earnings (PE) ratio for SARTORIUS STEDIM BIOTECH (56S1.DE) is 47.49 and the Price/Book (PB) ratio is 4.94.
What is the earnings growth outlook for SARTORIUS STEDIM BIOTECH?
The Earnings per Share (EPS) of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 29.12% in the next year.